Metraipolis › archive › dc_2cb21c350fa0

Disparities in smokeless tobacco use in Bangladesh, India, and Pakistan: Findings from the Global Adult Tobacco Survey, 2014-2017 — Europe PMC PMID:33886617

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33886617
DOI
10.1371/journal.pone.0250144
License (as archived)
CC0-1.0
Archived
2026-11-05T00:02:55.628Z
SHA-256 of the archived text
8b490060cd0677b7334dfd19e1acbeec8b52bd834f3401bb7b195e76ac9b24b1
Stable URL of this page
https://metraipolis.com/documento/dc_2cb21c350fa0

How to cite

Disparities in smokeless tobacco use in Bangladesh, India, and Pakistan: Findings from the Global Adult Tobacco Survey, 2014-2017 — Europe PMC PMID:33886617 — Europe PMC (en), https://europepmc.org/article/MED/33886617 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_2cb21c350fa0 (Metraipolis archive dc_2cb21c350fa0, sha256 8b490060cd0677b7334dfd19e1acbeec8b52bd834f3401bb7b195e76ac9b24b1)
BibTeX
@misc{dc2cb21c350fa0,
  title = {Disparities in smokeless tobacco use in Bangladesh, India, and Pakistan: Findings from the Global Adult Tobacco Survey, 2014-2017 — Europe PMC PMID:33886617},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33886617},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_2cb21c350fa0; sha256 8b490060cd0677b7334dfd19e1acbeec8b52bd834f3401bb7b195e76ac9b24b1},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33886617. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Smokeless tobacco (SLT) use is associated with multiple adverse health effects. It is prominent in Bangladesh, India, and Pakistan, but disparities in use within and across these countries are not well documented or understood. This study assessed the prevalence, patterns, and correlates of SLT use in these three countries. Method: Data came from the Global Adult Tobacco Survey, a household survey of adults aged ≥15 years. Data were collected in 2014 (Pakistan), 2017 (Bangladesh), and India (2016-2017). Current SLT use (nasal or oral use) was defined as reported SLT use daily or less than daily at the time of the survey. Prevalence of both overall and specific SLT types were assessed. Multivariate logistic regression was used to assess correlates of SLT use. Results: Overall, SLT use among adults ≥15 years of age was 20.6% in Bangladesh, 21.4% in India, and 7.7% in Pakistan, corresponding to 22.0 million SLT users in Bangladesh, 199.4 million in India, and 9.6 million in Pakistan. Among current tobacco users overall, the percentage of those who used SLT was 58.4% (CI: 56.0-60.7) in Bangladesh, 74.7% (CI: 73.4-76.0) in India, and 40.3% (CI: 36.2-44.5) in Pakistan. The most commonly used oral SLT product was Zarda (14.5%) in Bangladesh, Khaini (11.2%) in India, and Naswar (5.1%) in Pakistan. Females had greater odds of SLT use than males in Bangladesh, but lower odds of SLT use than males in India and Pakistan. In all three countries, the odds of SLT use was higher among those 25 years and older, lower education, lower wealth index, and greater exposure to SLT marketing. Conclusion: An estimated 231 million adults aged 15 years or older currently use SLT in Bangladesh, India, and Pakistan, comprising 40.3%-74.7% of overall tobacco product use in these countries. Moreover, marked variations in SLT use exist by population groups. Furthermore, exposure to pro-SLT marketing was found to be associated with higher SLT use compared to non-exposed. It is important that tobacco control strategies address all forms of tobacco product use, including SLT.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-04-22).
Identificativi: PMID 33886617 · PMCID PMC8062090 · DOI 10.1371/journal.pone.0250144.
Descrittori MeSH principali: Tobacco, Smokeless.
Pagina: https://europepmc.org/article/MED/33886617 — https://doi.org/10.1371/journal.pone.0250144. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-04T23:59:29.330Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.